ABSTRACT
Introduction While much research effort is concentrated on understanding the different aspects of Alzheimer’s disease (AD) - physiological, psychological and social - the impact and adoption of new therapies will be dependent, to a considerable degree, upon dissemination of information to healthcare professionals and other formal care-givers. More and more, the emphasis is on evidence-based care. Family care-givers, as a particularly vulner able group, also require information about the disease itself and about services which they can access, in order to be able to respond to problems they may face from time to time.
